Please Take This Survey (and How Many Times Can We Say Thank You?)

In this digital era, we ask a lot more of you, our readers--to answer poll questions, provide feedback on articles, and most importantly to provide input for our surveys on key industry topics. Well, here we go again. There are two surveys that we'd love to get your input on:

Our 2010 Job Satisfaction and Salary Survey: We'll feature data in our February issue, and on PharmaManufacturing.com, and look forward to hearing your thoughts about your work life and career.

BioPlan Associates' 7th Annual Report and Survey of Biopharmaceutical Manufacturing: BioPlan's survey is truly unique in its breadth of topics covered and depth of input from the industry. We encourage you to participate, and will work with BioPlan to share results in our magazine pages later this year (and on PharmaManufacturing.com).

We literally can't thank you enough for your support, and are looking for ways to acknowledge your participation in these surveys. This year, for our job and salary survey, we're donating money to a charity that we think is worthy and relevant to the work we all do: St. Jude Children's Research Hospital. What better way is there to encourage you to help us out?

BioPlan's way of saying thanks is to provide you with an extensive free summary of results for your participation.

These surveys are important ways for us to measure how the pharmaceutical and biopharma industry are doing, and to share this data for the benefit of all. Again, we've said it before, but thank you so much.

 

 

 

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

  • <p>Schluterman and Smith have been researching lawyer reporting in AERS, and Schluterman presented their findings at the DIA 2011 conference in Chicago this week. View the poster PDF her <a href="http://www.googleplus1king.com/">buy google +1</a> </p>

    Reply

RSS feed for comments on this page | RSS feed for all comments